🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06314594
Recruiting Not applicable

Personalized Prevention and Treatment Strategies for Adolescent Idiopathic Scoliosis Via a Comprehensive Health Management Platform

NCT06314594 · tracked via the Priya Life Science China tracker
Sponsor
Hangzhou Medical College
Phase
Not applicable
Started
2025-08-01
Last updated
2026-02-23

Condition(s) studied

Adolescent Idiopathic Scoliosis (AIS)

Investigational drug(s) / intervention(s)

Conventional treatmentintervention treatment

Conventional treatment: Patients will randomly assigned to routine treatment group (control group) and individualized treatment model group (intervention group). All patients will observed and intervened for 4 months. Patients in the control treatment group will follow the treatment plan in the 2016SOSORT guidelines

intervention treatment: Patients will be input into the health management platform. The optimal treatment scheme will be then determined through data calculation and sent to individuals (or their families) or schools for implementation under the guidance of the platform. It is important to note that the specific treatment plan varied from person to person. Patients were observed and intervened for a period of 4 months. 1. Massage therapy 2. Posture guidance 3. Schroeder\'s gymnastics therapy 4. Bioelectric stimulation therapy

Study summary

Spinal cord injury (SCI), leads to functional deficits and complications like neurogenic bladder and deep vein thrombosis, imposing a global annual financial burden. This trial aims to compares Jiaji electroacupuncture (JEA) and scalp electroacupuncture (SEA) in SCI rehabilitation. This randomized controlled trial (RCT) compared JEA and SEA in SCI rehabilitation.

Eligibility

Sex
ALL
Min age
3 Years
Max age
18 Years
Healthy volunteers
Accepted
Inclusion Criteria: 1. The diagnosis of moderate and mild AIS, with a Cobb angle measuring less than 45°; 2. The age range of 12 to 16 years old; 3. Participants are required to have no history of mental illness, possess normal communication skills, and be proficient in reading and writing; 4. Signed informed consent by the patient or their family. Exclusion Criteria: Patients who fulfill any of the following conditions will be excluded a clear history of inducement, such as diseases caused by trauma, surgery, cognitive impairment, severe dysfunction of heart, liver, kidney and other organs, and malignant tumors, immune diseases and other malignant diseases.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
the Affiliated Zhejiang Provincial People's Hospital to Hangzhou Medical College. Hangzhou Zhejiang Recruiting

More Hangzhou Medical College trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06314594 on ClinicalTrials.gov ↗ ← All trials in China